Paul Tudor Jones’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.94M | Buy |
567,250
+351,698
| +163% | +$1.09M | ﹤0.01% | 1965 |
|
|
2026
Q1 | $491K | Buy |
215,552
+95,877
| +80% | +$221K | ﹤0.01% | 2827 |
|
|
2025
Q4 | $335K | Sell |
119,675
-341,577
| -74% | -$1.22M | ﹤0.01% | 2976 |
|
|
2025
Q3 | $2.21M | Buy |
461,252
+234,376
| +103% | +$1.49M | ﹤0.01% | 1739 |
|
|
2025
Q2 | $2.06M | Sell |
226,876
-186,404
| -45% | -$1.37M | ﹤0.01% | 1650 |
|
|
2025
Q1 | $3.73M | Buy |
+413,280
| New | +$4.36M | 0.01% | 952 |
|
|
2024
Q1 | – | Sell |
-38,242
| Closed | -$737K | – | 2638 |
|
|
2023
Q4 | $737K | Sell |
38,242
-155,135
| -80% | -$2.81M | 0.01% | 1594 |
|
|
2023
Q3 | $3.12M | Buy |
193,377
+29,781
| +18% | +$529K | 0.03% | 714 |
|
|
2023
Q2 | $3.11M | Sell |
163,596
-22,943
| -12% | -$409K | 0.04% | 666 |
|
|
2023
Q1 | $2.71M | Buy |
186,539
+76,934
| +70% | +$1.38M | 0.04% | 624 |
|
|
2022
Q4 | $2.14M | Buy |
+109,605
| New | +$2.14M | 0.04% | 609 |
|
|
2022
Q2 | – | Sell |
-52,088
| Closed | -$2.29M | – | 2406 |
|
|
2022
Q1 | $2.29M | Buy |
52,088
+39,783
| +323% | +$1.71M | 0.05% | 482 |
|
|
2021
Q4 | $535K | Buy |
+12,305
| New | +$482K | 0.01% | 1417 |
|
|
2021
Q3 | – | Sell |
-18,679
| Closed | -$791K | – | 2703 |
|
|
2021
Q2 | $791K | Sell |
18,679
-18,565
| -50% | -$722K | 0.01% | 957 |
|
|
2021
Q1 | $1.4M | Buy |
+37,244
| New | +$1.16M | 0.03% | 682 |
|
|
2018
Q2 | – | Sell |
-21,700
| Closed | -$337K | – | 1182 |
|
|
2018
Q1 | $337K | Buy |
+21,700
| New | +$387K | 0.01% | 695 |
|
|
2017
Q2 | – | Sell |
-27,723
| Closed | -$959K | – | 1280 |
|
|
2017
Q1 | $959K | Buy |
27,723
+7,301
| +36% | +$261K | 0.03% | 398 |
|
|
2016
Q4 | $721K | Buy |
20,422
+12,641
| +162% | +$427K | 0.02% | 527 |
|
|
2016
Q3 | $270K | Sell |
7,781
-2,919
| -27% | -$102K | 0.01% | 1096 |
|
|
2016
Q2 | $400K | Sell |
10,700
-12,033
| -53% | -$452K | 0.01% | 995 |
|
|
2016
Q1 | $919K | Buy |
22,733
+7,733
| +52% | +$288K | 0.02% | 556 |
|
|
2015
Q4 | $540K | Sell |
15,000
-235,000
| -94% | -$8.5M | 0.02% | 821 |
|
|
2015
Q3 | $7.99M | Buy |
250,000
+222,600
| +812% | +$7.58M | 0.27% | 66 |
|
|
2015
Q2 | $932K | Buy |
27,400
+400
| +1% | +$13.5K | 0.03% | 455 |
|
|
2015
Q1 | $914K | Buy |
27,000
+3,226
| +14% | +$112K | 0.03% | 422 |
|
|
2014
Q4 | $835K | Buy |
23,774
+1,174
| +5% | +$39.5K | 0.03% | 439 |
|
|
2014
Q3 | $740K | Sell |
22,600
-8,037
| -26% | -$274K | 0.03% | 438 |
|
|
2014
Q2 | $1.04M | Sell |
30,637
-8,199
| -21% | -$281K | 0.04% | 194 |
|
|
2014
Q1 | $1.36M | Buy |
38,836
+21,456
| +123% | +$757K | 0.06% | 139 |
|
|
2013
Q4 | $635K | Buy |
17,380
+7,280
| +72% | +$267K | 0.03% | 401 |
|
|
2013
Q3 | $349K | Buy |
10,100
+600
| +6% | +$21K | 0.01% | 515 |
|
|
2013
Q2 | $321K | Buy |
+9,500
| New | +$315K | 0.02% | 523 |
|
Other funds holding ACH
CCM
ICM
PCMI
Paul Tudor Jones's ACH Position: Q2 2026 in Review
Paul Tudor Jones increased its Accendra Health (ACH) stake by 163% in Q2 2026, buying an estimated $1.09M and bringing the position to 567,250 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1965.
Paul Tudor Jones first reported a position in ACH in Q2 2013 and has held it in 32 quarters since. The position peaked at $7.99M in Q3 2015. 138 funds tracked by Wall St. Rank hold ACH as of Q2 2026.
- Paul Tudor Jones held 567,250 shares of Accendra Health worth $1.94M as of Q2 2026.
- Paul Tudor Jones bought 351,698 Accendra Health shares in Q2 2026, an estimated $1.09M.
- Accendra Health made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1965 holding.
- Paul Tudor Jones first reported a position in Accendra Health in Q2 2013 and has held it in 32 quarters since.
- Paul Tudor Jones's Accendra Health position peaked at $7.99M in Q3 2015.
- 138 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.
Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.